Bridging from cells to cognition in autism pathophysiology: Biological pathways to defective brain function and plasticity

American Journal of Biochemistry and Biotechnology

Volumn 4, Issue 2, 2008, Pages 167-176

  Anderson, Matthew P ^a   Hooker, Brian S ^b   Herbert, Martha R ^c,d  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d CAMBRIDGE HEALTH ALLIANCE   (United States)

Author keywords

BDNF; Dendritic beading; Inflammation; Mitochondria; ROS; Synaptic plasticity

Indexed keywords

DNA; ENZYME ACTIVITY; MITOCHONDRIA; NEUROLOGY; PHYSIOLOGICAL MODELS;

DENDRITIC BEADING; PATHOPHYSIOLOGY:; REACTIVE OXYGEN SPECIES (ROS); SYNAPTIC PLASTICITY;

BRAIN;

AUTISM; AUTOIMMUNITY; BRAIN DYSFUNCTION; COGNITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; EXCITOTOXICITY; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INNATE IMMUNITY; MACROGLIA; MEDICAL TECHNOLOGY; MICROGLIA; MITOCHONDRION; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW; SEIZURE; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 42449090562     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbbsp.2008.167.176     Document Type: Review

References (76)

1. Belmonte, M.K. and T. Bourgeron, 2006. Fragile X syndrome and autism at the intersection of genetic and neural networks. Nat. Neurosci., 9: 1221-1225.
2. Redcay, E. and E. Courchesne, 2005. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol. Psychiatry, 58: 1-9.
3. Herbert, M.R., 2005. Large brains in autism: the challenge of pervasive abnormality. Neuroscientist, 11: 417-440.
4. Bauman, M.L. and T.L. Kemper, 2005. Neuroanatomic observations of the brain in autism: a review and future directions. Int. J. Dev. Neurosci., 23: 183-187.
5. Aylward, E.H., N.J. Minshew, K. Field, B.F. Sparks and N. Singh, 2002. Effects of age on brain volume and head circumference in autism. Neurology, 59: 175-183.
6. Shavelle, R.M., D.J. Strauss and J. Pickett, 2001. Causes of death in autism. J. Autism Dev. Disord., 31: 569-576.
7. Rimland, B., Infantile autism; the syndrome and its implications for a neural theory of behavior. 1964, [New York],: Appleton-Century-Crofts. xi, pp: 282.
8. Horwitz, B., J.M. Rumsey, C.L. Grady and S.I. Rapoport, 1988. The cerebral metabolic landscape in autism: Intercorrelations of regional glucose utilization. Arch. Neurol., 45: 749-755.
9. Just, M.A., V.L. Cherkassky, T.A. Keller and N.J. Minshew, 2004. Cortical activation and synchronization during sentence comprehension in high-functioning autism: evidence of underconnectivity. Brain, 127: 1811-1821.
10. Rippon, G., J. Brock, C. Brown and J. Boucher, 2007. Disordered connectivity in the autistic brain: challenges for the new psychophysiology. Int. J. Psychophysiol., 63: 164-172.
11. Courchesne, E. and K. Pierce, 2005. Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr. Opin. Neurobiol., 15: 225-230.
12. Belmonte, M.K., G. Allen, A. Beckel-Mitchener, L.M. Boulanger, R.A. Carper and S.J. Webb, 2004. Autism and abnormal development of brain connectivity. J. Neurosci., 24: 9228-9231.
13. Hendry, J., T. DeVito, N. Gelman, M. Densmore, N. Rajakumar, W. Pavlosky, P.C. Williamson, P.M. Thompson, D.J. Drost and R. Nicolson, 2006. White matter abnormalities in autism detected through transverse relaxation time imaging. Neuroimage, 29: 1049-1057.
14. Palmen, S.J., H. van Engeland, P.R. Hof and C. Schmitz, 2004. Neuropathological findings in autism. Brain, 127: 2572-2583.
15. Herbert, M.R. and V.S. Caviness, Autism: A neurobiological disorder of early brain development, in Neuroanatomy and Imaging Studies, R. Tuchman and I. Rapin, Editors. 2006, Mac Keith Press. 115-140.
16. Gustafsson, L., 2004. Comment on Disruption in the inhibitory architecture of the cell minicolumn: implications for autism. Neuroscientist, 10: 189-191.
17. Kern, J.K., 2003. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev., 25: 377-382.
18. Kemper, T.L., M.L. Bauman and G.J. Blatt, 2004. Calcium-binding proteins in cerebellar Purkinje cells in the autistic cerebellum. in Society for Neurosciences.
19. Kelley, E., D. Fein and L. Naigles, 2007. Language functioning in optimal outcome children with a history of autism spectrum disorders. J. Autism Dev. Disord., In press.
20. Fein, D., P. Dixon, J. Paul and H. Levin, 2005. Brief report: pervasive developmental disorder can evolve into ADHD: case illustrations. J Autism Dev. Disord., 35: 525-534.
21. Curran, L.K., et al., 2007. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics, In Press.
22. Brown, G., 1999. The sometimes son - fever may temporarily cure autism. Humanist, 59: 46-47.
23. Cotterill, R.M., 1985. Fever in autistics. Nature, 313: 426.
24. Cotterill, R.M., 1986.The Brain: An Intriguing Piece of Condensed Matter. Physica Scripta, T13: 161-168.
25. Oliveira, G., L. Diogo, M. Grazina, P. Garcia, A. Ataide, C. Marques, T. Miguel, L. Borges, A.M. Vicente and C.R. Oliveira, 2005. Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev. Med. Child Neurol., 47: 185-189.
26. Correia, C., A.M. Coutinho, L. Diogo, M. Grazina, C. Marques, T. Miguel, A. Ataide, J. Almeida, L. Borges, C. Oliveira, G. Oliveira and A.M. Vicente, 2006. Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J. Autism Dev. Disord., 36: 1137-1140.
27. Filipek, P.A., J. Juranek, M.T. Nguyen, C. Cummings and J.J. Gargus, 2004. Relative carnitine deficiency in autism. J. Autism Dev. Disord., 34: 615-623.
28. Vargas, D.L., C. Nascimbene, C. Krishnan, A.W. Zimmerman and C.A. Pardo, 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neuro., 57: 67-81.
29. Colton, C.A. and D.L. Gilbert, 1987. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett., 223: 284-288.
30. Moss, D.W. and T.E. Bates, 2001. Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function. Eur. J. Neurosci., 13: 529-538.
31. Liu, B., H.M. Gao, J.Y. Wang, G.H. Jeohn, C.L. Cooper and J.S. Hong, 2002. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann. N. Y. Acad. Sci., 962: 318-31.
32. Li, J., O. Baud, T. Vartanian, J.J. Volpe and P.A. Rosenberg, 2005. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl. Acad. Sci. USA, 102: 9936-9941.
33. Zieminska, E., E. Matyja, H. Kozlowska, A. Stafiej and J.W. Lazarewicz, 2006. Excitotoxic neuronal injury in acute homocysteine neurotoxicity: role of calcium and mitochondrial alterations. Neurochem. Int., 48: 491-497.
34. Kruman, I.I., C. Culmsee, S.L. Chan, Y. Kruman, Z. Guo, L. Penix and M.P. Mattson, 2000. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci., 20: 6920-6926.
35. Blount, B.C., M.M. Mack, C.M. Wehr, J.T. MacGregor, R.A. Hiatt, G. Wang, S.N. Wickramasinghe, R.B. Everson and B.N. Ames, 1997. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl. Acad. Sci. USA, 94: 3290-3295.
36. Patterson, P.H., 2002. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr. Opin. Neurobiol., 12: 115-118.
37. Poirier, M.C., R.L. Divi, L. Al-Harthi, O.A. Olivero, V. Nguyen, B. Walker, A.L. Landay, V.E. Walker, M. Charurat, W.A. Blattner and Women and Infants Transmission Study (WITS) Group, 2003. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J. Acquir. Immune Defic. Syndr., 33: 175-183.
38. Ohyama, K., T. Sano and H. Toyoda, 2004. Predominant contribution of IFN-beta expression to apoptosis induction in human uterine cervical fibroblast cells by influenza-virus infection. Biol. Pharm. Bull., 27: 1750-1757.
39. Campbell, D.B., J.S. Sutcliffe, P.J. Ebert, R. Militerni, C. Bravaccio, S. Trillo, M. Elia, C. Schneider, R. Melmed, R. Sacco, A.M. Persico and P. Levitt, 2006. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. USA, 103: 16834-16839.
40. Yo, Y., R. Morishita, K. Yamamoto, N. Tomita, I. Kida, S. Hayashi, A. Moriguchi, S. Kato, K. Matsumoto, T. Nakamura, J. Higaki and T. Ogihara, 1998. Actions of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease. Kidney Int., 53: 50-58.
41. Elliott, B.E., W.L. Hung, A.H. Boag and A.B. Tuck, 2002. The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer. Can. J. Physiol. Pharmacol., 80: 91-102.
42. Sugihara, G., K. Hashimoto, Y. Iwata, K. Nakamura, M. Tsujii, K.J. Tsuchiya, Y. Sekine, K. Suzuki, S. Suda, H. Matsuzaki, M. Kawai, Y. Minabe, A. Yagi, N. Takei, T. Sugiyama and N. Mori, 2007. Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism. Prog Neuropsychopharmacol Biol. Psychiatry, 31: 412-415.
43. Nagayama, T., M. Nagayama, S. Kohara, H. Kamiguchi, M. Shibuya, Y. Katoh, J. Itoh and Y. Shinohara, 2004. Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia. Brain Res., 999: 155-166.
44. Shimamura, M., N. Sato, S. Waguri, Y. Uchiyama, T. Hayashi, H. Iida, T. Nakamura, T. Ogihara, Y. Kaneda and R. Morishita, 2006. Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction. Hypertension, 47: 742-751.
45. Badie, B., J. Schartner, J. Klaver and J. Vorpahl, 1999. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery, 44: 1077-1082; discussion 1082-1083.
46. Zhang, X. and Y. Liu, 2003. Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1. Am. J. Physiol. Renal Physiol., 284: F1216-F1225.
47. Lavrovsky, Y., B. Chatterjee, R.A. Clark and A.K. Roy, 2000. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp. Gerontol., 35: 521-532.
48. Bijur, G.N., R.E. Davis and R.S. Jope, 1999. Rapid activation of heat shock factor-1 DNA binding by H2O2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res. Mol. Brain Res., 71: 69-77.
49. Thiriet, N., J. Zwiller and S.F. Ali, 2001. Induction of the immediate early genes egr-1 and c-fos by methamphetamine in mouse brain. Brain Res., 919: 31-40.
50. Li, Z., S. Mizuno and T. Nakamura, 2007. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases. Am. J. Physiol. Gastrointest. Liver Physiol., 292: G639-646.
51. Ekuni, D., J.D. Firth and E.E. Putnins, 2006. Regulation of epithelial cell growth factor receptor protein and gene expression using a rat periodontitis model. J. Periodontal Res., 41: 340-349.
52. Kurz, S.M., S.S. Diebold, T. Hieronymus, T.C. Gust, P. Bartunek, M. Sachs, W. Birchmeier and M. Zenke, 2002. The impact of c-met/scatter factor receptor on dendritic cell migration. Eur. J. Immunol., 32: 1832-1838.
53. Masliah, E., N. Ge, M. Morey, R. DeTeresa, R.D. Terry and C.A. Wiley, 1992. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest., 66: 285-291.
54. Brendza, R.P., B.J. Bacskai, J.R. Cirrito, K.A. Simmons, J.M. Skoch, W.E. Klunk, C.A. Mathis, K.R. Bales, S.M. Paul, B.T. Hyman and D.M. Holtzman, 2005. Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J. Clin. Invest., 115: 428-433.
55. Hasbani, M.J., K.L. Hyrc, B.T. Faddis, C. Romano and M.P. Goldberg, 1998. Distinct roles for sodium, chloride and calcium in excitotoxic dendritic injury and recovery. Exp. Neurol., 154: 241-258.
56. Swann, J.W., S. Al-Noori, M. Jiang and C.L. Lee, 2000. Spine loss and other dendritic abnormalities in epilepsy. Hippocampus, 10: 617-625.
57. Bellizzi, M.J., S.M. Lu, E. Masliah and H.A. Gelbard, 2005. Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor. J. Clin. Invest., 115: 3185-3192.
58. Ikegaya, Y., J.A. Kim, M. Baba, T. Iwatsubo, N. Nishiyama and N. Matsuki, 2001. Rapid and reversible changes in dendrite morphology and synaptic efficacy following NMDA receptor activation: implication for a cellular defense against excitotoxicity. J. Cell. Sci., 114: 4083-4093.
59. McHugh, T.J., K.I. Blum, J.Z. Tsien, S. Tonegawa and M.A. Wilson, 1996. Impaired hippocampal representation of space in CA1-specific NMDAR1 knockout mice. Cell, 87: 1339-1349.
60. Tsien, J.Z., P.T. Huerta and S. Tonegawa, 1996. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell, 87: 1327-1338.
61. Raymond, G.V., M.L. Bauman and T.L. Kemper, 1996. Hippocampus in autism: a Golgi analysis. Acta Neuropathol. (Berl), 91: 117-119.
62. Magee, J.C. and D. Johnston, 1997. A synaptically controlled, associative signal for Hebbian plasticity in hippocampal neurons. Science, 275: 209-213.
63. Markram, H., J. Lubke, M. Frotscher and B. Sakmann, 1997. Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs. Science, 275: 213-215.
64. Dan, Y. and M.M. Poo, 2006. Spike timing-dependent plasticity: from synapse to perception. Physiol. Rev., 86: 1033-1048.
65. Bi, G.Q. and M.M. Poo, 1998. Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength and postsynaptic cell type. J. Neurosci., 18: 10464-10472.
66. Gibson, J.R., M. Beierlein and B.W. Connors, 1999. Two networks of electrically coupled inhibitory neurons in neocortex. Nature, 402: 75-79.
67. Cobb, S.R., E.H. Buhl, K. Halasy, O. Paulsen and P. Somogyi, 1995. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature, 378: 75-78.
68. Coull, J.A., S. Beggs, D. Boudreau, D. Boivin, M. Tsuda, K. Inoue, C. Gravel, M.W. Salter and Y. De Koninck, 2005. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature, 438: 1017-1021.
69. Rivera, C., H. Li, J. Thomas-Crusells, H. Lahtinen, T. Viitanen, A. Nanobashvili, Z. Kokaia, M.S. Airaksinen, J. Voipio, K. Kaila and M. Saarma, 2002. BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion. J. Cell Biol., 159: 747-752.
70. Anderson, M.P., T. Mochizuki, J. Xie, W. Fischler, J.P. Manger, E.M. Talley, T.E. Scammell and S. Tonegawa, 2005. Thalamic Cav3.1 T-type Ca2+ channel plays a crucial role in stabilizing sleep. Proc. Natl. Acad. Sci. USA, 102: 1743-1748.
71. McVicar, K.A. and S. Shinnar, 2004. Landau-Kleffner syndrome, electrical status epilepticus in slow wave sleep and language regression in children. Ment. Retard. Dev. Disabil. Res. Rev., 10: 144-149.
72. Trevathan, E., 2004. Seizures and epilepsy among children with language regression and autistic spectrum disorders. J. Child Neurol., 19 (Suppl 1): S49-57.
73. Saper, C.B., T.C. Chou and J.K. Elmquist, 2002. The need to feed: homeostatic and hedonic control of eating. Neuron, 36: 199-211.
74. Saper, C.B., T.E. Scammell and J. Lu, 2005. Hypothalamic regulation of sleep and circadian rhythms. Nature, 437: 1257-1263.
75. Hammock, E.A. and L.J. Young, 2006. Oxytocin, vasopressin and pair bonding: implications for autism. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 361: 2187-2198.
76. Billups, B. and I.D. Forsythe, 2002. Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J. Neurosci., 22: 5840-5847.